Jaguar Health
JAGX
3 hedge funds and large institutions have $223K invested in Jaguar Health in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
533% more capital invested
Capital invested by funds: $35.2K → $223K (+$188K)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$194K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$23.4K |
JAGX Hedge Fund Activity: Q3 2025 in Review
3 of the 7,646 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q3 2025, worth a combined $223K — up 533% from $35.2K a quarter earlier.
Fund positioning in JAGX was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was DRW Securities, opening a new position worth an estimated $194K. The largest seller was UBS Group, exiting entirely with an estimated $23.4K sold.
- 3 institutional investors held Jaguar Health (JAGX) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $223K of Jaguar Health stock for Q3 2025, up 533% quarter-over-quarter.
- 1 fund opened new Jaguar Health positions in Q3 2025 and 1 closed out, a net change of 0 holders.
- The largest Jaguar Health buyer in Q3 2025 was DRW Securities, an estimated $194K added.
- The largest Jaguar Health seller in Q3 2025 was UBS Group, an estimated $23.4K sold.
Based on aggregated 13F filings for Q3 2025.